UBS Group AG - AXOVANT GENE THERAPIES LTD ownership

Back to all holdings Add to watchlist

AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 1 filers reported holding AXOVANT GENE THERAPIES LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
UBS Group AG ownership history of AXOVANT GENE THERAPIES LTD
ValueSharesWeighting
Q3 2020$19,000
+375.0%
4,156
+211.5%
0.00%–
Q2 2020$4,000
-82.6%
1,334
-70.1%
0.00%–
Q4 2019$23,000
-90.3%
4,469
-87.8%
0.00%–
Q3 2019$236,000
+29.7%
36,517
+25.3%
0.00%–
Q2 2019$182,000–29,144–0.00%–
 Download
Other shareholders

There were no reported owners of AXOVANT GENE THERAPIES LTD in Q4 2020.

NameSharesValueWeighting ↓
View complete list of AXOVANT GENE THERAPIES LTD shareholders